These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1591735)

  • 1. Chronic administration of L-dopa affects the movement-related cortical potentials of patients with Parkinson's disease.
    Feve AP; Bathien N; Rondot P
    Clin Neuropharmacol; 1992 Apr; 15(2):100-8. PubMed ID: 1591735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in movement-related cortical potentials in Parkinson's patients before and after treatment with levodopa].
    Feve AP; Bathien N; Rondot P
    Neurophysiol Clin; 1991 May; 21(2):105-19. PubMed ID: 1921938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal movement related potentials in patients with lesions of basal ganglia and anterior thalamus.
    Fève A; Bathien N; Rondot P
    J Neurol Neurosurg Psychiatry; 1994 Jan; 57(1):100-4. PubMed ID: 8301287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Bereitschaftspotential, L-DOPA and Parkinson's disease.
    Dick JP; Cantello R; Buruma O; Gioux M; Benecke R; Day BL; Rothwell JC; Thompson PD; Marsden CD
    Electroencephalogr Clin Neurophysiol; 1987 Mar; 66(3):263-74. PubMed ID: 2434310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contingent negative variation and movement-related cortical potentials in parkinsonism.
    Oishi M; Mochizuki Y; Du C; Takasu T
    Electroencephalogr Clin Neurophysiol; 1995 Nov; 95(5):346-9. PubMed ID: 7489663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Movement-related cortical potentials (MRCPs) and voluntary movement--clinical usefulness of MRCPs].
    Washimi Y; Saitou K
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1525-7. PubMed ID: 8752452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Event-related desynchronization and Parkinson disease. Importance in the analysis of the phase of preparation for movement].
    Defebvre L; Derambure P; Bourriez JL; Destée A; Guieu JD
    Neurophysiol Clin; 1999 Feb; 29(1):71-89. PubMed ID: 10093819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortical potentials preceding voluntary movement: evidence for three periods of preparation in man.
    Barrett G; Shibasaki H; Neshige R
    Electroencephalogr Clin Neurophysiol; 1986 Apr; 63(4):327-39. PubMed ID: 2419090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of chronic administration of L-DOPA on event-related desynchronization of mu rhythm preceding voluntary movement in Parkinson's disease.
    Defebvre L; Bourriez JL; Derambure P; Duhamel A; Guieu JD; Destee A
    Electroencephalogr Clin Neurophysiol; 1998 Apr; 109(2):161-7. PubMed ID: 9741807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human eye fields in the frontal lobe as studied by epicortical recording of movement-related cortical potentials.
    Yamamoto J; Ikeda A; Satow T; Matsuhashi M; Baba K; Yamane F; Miyamoto S; Mihara T; Hori T; Taki W; Hashimoto N; Shibasaki H
    Brain; 2004 Apr; 127(Pt 4):873-87. PubMed ID: 14960503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of L-Dopa on the pattern of movement-related (de)synchronisation in advanced Parkinson's disease.
    Devos D; Labyt E; Derambure P; Bourriez JL; Cassim F; Guieu JD; Destée A; Defebvre L
    Neurophysiol Clin; 2003 Nov; 33(5):203-12. PubMed ID: 14672820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subthalamic nucleus stimulation modulates motor cortex oscillatory activity in Parkinson's disease.
    Devos D; Labyt E; Derambure P; Bourriez JL; Cassim F; Reyns N; Blond S; Guieu JD; Destée A; Defebvre L
    Brain; 2004 Feb; 127(Pt 2):408-19. PubMed ID: 14691060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute effects of L-dopa on event-related desynchronization in Parkinson's disease.
    Magnani G; Cursi M; Leocani L; Volonté MA; Comi G
    Neurol Sci; 2002 Sep; 23(3):91-7. PubMed ID: 12391492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of deep brain stimulation and L-Dopa on electrocortical rhythms related to movement in Parkinson's disease.
    Devos D; Defebvre L
    Prog Brain Res; 2006; 159():331-49. PubMed ID: 17071241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of internal globus pallidus stimulation on motor cortex activation pattern in Parkinson's disease.
    Devos D; Derambure P; Bourriez JL; Cassim DF; Blond S; Guieu JD; Destée A; Defebvre L
    Clin Neurophysiol; 2002 Jul; 113(7):1110-20. PubMed ID: 12088707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Age-related changes in movement-related cortical potentials].
    Ishizuka H; Tomi H; Sunohara N
    Nihon Ronen Igakkai Zasshi; 1996 Aug; 33(8):586-91. PubMed ID: 8921696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of premovement components of movement-related cortical potentials in patients with Parkinson's disease or brain tumors.
    Oki H; Matsumoto K; Okada J; Shichijo F
    Stereotact Funct Neurosurg; 1990; 54-55():193-206. PubMed ID: 2080336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levodopa reinstates connectivity from prefrontal to premotor cortex during externally paced movement in Parkinson's disease.
    Herz DM; Siebner HR; Hulme OJ; Florin E; Christensen MS; Timmermann L
    Neuroimage; 2014 Apr; 90():15-23. PubMed ID: 24269570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic-pharmacodynamic modeling of levodopa in patients with advanced Parkinson disease.
    Adamiak U; Kaldonska M; Klodowska-Duda G; Wyska E; Safranow K; Bialecka M; Gawronska-Szklarz B
    Clin Neuropharmacol; 2010 May; 33(3):135-41. PubMed ID: 20216409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortical potential shifts preceding voluntary movement are normal in parkinsonism.
    Barrett G; Shibasaki H; Neshige R
    Electroencephalogr Clin Neurophysiol; 1986 Apr; 63(4):340-8. PubMed ID: 2419091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.